FROG:NASDAQJFrog Ltd. Analysis
Data as of 2026-04-04 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
JFrog (FROG) is delivering robust top‑line momentum, with revenue climbing 25% year‑over‑year and a gross margin north of 75%, while its cash pile exceeds $700 M and free cash flow remains positive. Technically, the stock trades just above its 20‑day (≈ $44) and 50‑day (≈ $47) moving averages and has broken above the 200‑day line (≈ $50), the MACD histogram is bullish, and the RSI sits at a moderately high 62, suggesting continued upside momentum, yet the price is flirting with a near‑term resistance around $51. The 30‑day volatility exceeds 110% and a beta of roughly 1.3 flag a high‑risk profile, while a max drawdown of nearly 50% underscores historical downside pressure. Valuation models place the intrinsic value near $60, implying roughly a 38% upside from the current $50.6 price, even though the forward P/E of 46× sits above the industry average of 33×. Recent market sentiment is mixed: a 24.6% plunge followed Anthropic’s Claude Code Security launch, while a 32% rally was sparked by heightened security demand after a high‑profile NPM supply‑chain breach, and the CTO’s $2.5 M share sale added a touch of skepticism. The Fear & Greed Index at 78.8 signals “Extreme Greed,” indicating that investors remain optimistic despite the volatility and competitive pressures.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near resistance and vulnerable to a pullback after the Claude Code Security announcement
- Elevated short‑term volatility and high beta
- Recent insider selling by the CTO
Medium Term
1–3 yearsKey Factors
- Strong revenue growth and high gross margins supporting a turnaround to profitability
- Positive cash generation and a sizable cash cushion
- DCF‑derived upside of ~38% versus current price
Long Term
> 3 yearsKey Factors
- Secular demand for software supply‑chain security and DevOps platforms
- Analyst consensus (strong‑buy) and target prices near $70
- Strategic positioning to capture market share after high‑profile supply‑chain incidents
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.